6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9 Maʻemaʻe ≥99.0% Favipiravir Intermediate COVID-19

ʻO ka wehewehe pōkole:

Inoa: 6-Bromo-3-Hydroxypyrazine-2-Carboxamide

CAS: 259793-88-9

Maʻemaʻe: ≥99.0%

Intermediate o Favipiravir (CAS 259793-96-9) i ka mālama ʻana i nā maʻi maʻi Influenza a me COVID-19

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Mea Hana me ka Maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Hāʻawi Kalepa Favipiravir a me nā mea pili e pili ana:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Na Waiwai Kemika:

Inoa Kimia	6-Bromo-3-Hydroxypyrazine-2-Carboxamide
Nā huaʻōlelo like	Favipiravir Intermediate;Favipiravir haumia 4
Helu CAS	259793-88-9
Helu CAT	RF-PI296
Kūlana Kūʻai	Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram
ʻĀpana Molekala	C5H4BrN3O2
Kaumaha Molecular	218.01
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Melemele māmā i ka pauda ʻulaʻula
ʻIkepili	IR, HPLC
Nalo ma ka maloo	≤1.0%
Koena ma ka Ignition	≤0.20%
Hoʻokahi haumia	≤0.50%
Huina paumaele	≤1.0%
Nā Metala Kaumaha	≤20ppm
Nā mea hoʻoheheʻe koena	Hoʻokō i ka kikoʻī
Kūlana hoʻāʻo	Kūlana ʻoihana
Hoʻohana	Kūwaena o Favipiravir (CAS 259793-96-9)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

FAQ:

Noi:

ʻO 6-Bromo-3-Hydroxypyrazine-2-Carboxamide (CAS 259793-88-9) he mea waena maʻamau i ka synthesis o 6-Bromo-3-Hydroxypyrazine-2-Carboxamide i kapa ʻia ʻo Favipiravir (CAS 259793-96-9) ka mālama ʻana i nā maʻi maʻi Influenza.ʻO kahi ala kūpono a hoʻokele waiwai i Favipiravir.ʻO Favipiravir kahi huahana noiʻi e pili ana i ka COVID19, i ka mālama ʻana i nā maʻi me COVID-19 i ʻōlelo ʻia e WHO.ʻO Favipiravir, i kapa ʻia ʻo T-705 a i ʻole Avigan, he lāʻau antiviral i hoʻomohala ʻia e Toyama Chemical (Fujifilm Group) o Iapana me ka hana kūʻē i nā maʻi RNA he nui.Ua ʻae ʻia ʻo Favipiravir no ke kūʻai aku ʻana ma Iapana i Malaki 2014 a ua hoʻohana ʻia no ka mālama antiviral o ka influenza A a me B. Ma waho aʻe o ka maʻi maʻi influenza, ua hōʻike pū ka lāʻau lapaʻau i ka hana antiviral maikaʻi i nā ʻano maʻi RNA like ʻole, e like me ka maʻi Ebola, Sand virus, ʻO ka maʻi Bunia, ka maʻi rabies, a me nā mea ʻē aʻe. I Pepeluali 2020 ua aʻo ʻia ʻo Favipiravir ma Kina no ka hoʻāʻo ʻana i ka maʻi COVID-19 (Novel Coronavirus) a ua hōʻike ʻia nā hopena maikaʻi.